PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(0.0%)
IDR 635.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -668.51 Billion IDR | 39.54% |
| 2022 | -1105.8 Billion IDR | -19.01% |
| 2021 | -929.14 Billion IDR | -6.53% |
| 2020 | -872.18 Billion IDR | -447.27% |
| 2019 | 251.15 Billion IDR | 20.97% |
| 2018 | 207.62 Billion IDR | 51.46% |
| 2017 | 137.08 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -331.22 Billion IDR | 47.32% |
| 2024 Q1 | -451.93 Billion IDR | 32.4% |
| 2024 Q2 | -617.56 Billion IDR | -36.65% |
| 2023 Q4 | -668.51 Billion IDR | -63.09% |
| 2023 FY | -668.51 Billion IDR | 39.54% |
| 2023 Q3 | -409.9 Billion IDR | 35.2% |
| 2023 Q2 | -632.57 Billion IDR | -5.86% |
| 2023 Q1 | -597.58 Billion IDR | 45.96% |
| 2022 Q3 | -897.67 Billion IDR | -8.64% |
| 2022 Q2 | -826.26 Billion IDR | 23.29% |
| 2022 Q1 | -1077.06 Billion IDR | -15.92% |
| 2022 FY | -1105.8 Billion IDR | -19.01% |
| 2022 Q4 | -1105.8 Billion IDR | -23.19% |
| 2021 Q4 | -929.14 Billion IDR | -27.12% |
| 2021 Q3 | -730.91 Billion IDR | -16.21% |
| 2021 Q2 | -628.98 Billion IDR | 32.91% |
| 2021 Q1 | -937.46 Billion IDR | -6.61% |
| 2021 FY | -929.14 Billion IDR | -6.53% |
| 2020 Q4 | -879.31 Billion IDR | -57.3% |
| 2020 Q1 | 294.61 Billion IDR | 17.3% |
| 2020 FY | -872.18 Billion IDR | -447.27% |
| 2020 Q3 | -558.98 Billion IDR | 0.0% |
| 2019 Q4 | 251.15 Billion IDR | 0.0% |
| 2019 FY | 251.15 Billion IDR | 20.97% |
| 2019 Q1 | 274.41 Billion IDR | 0.0% |
| 2018 FY | 207.62 Billion IDR | 51.46% |
| 2017 FY | 137.08 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | -683.1 Billion IDR | 2.136% |
| PT Itama Ranoraya Tbk | 148.83 Billion IDR | 549.178% |
| PT Kimia Farma (Persero) Tbk | 7094.31 Billion IDR | 109.423% |
| PT Millennium Pharmacon International Tbk | 651.43 Billion IDR | 202.622% |